0
Critical Care |

Extracorporeal Membrane Oxygenation in a Case of Refractory Status Asthmaticus in Pregnancy

Maria Theodorou, MD; Emily Gilbert, MD
Author and Funding Information

Loyola University Medical Center, Maywood, IL


Chest. 2015;148(4_MeetingAbstracts):279A. doi:10.1378/chest.2242000
Text Size: A A A
Published online

Abstract

SESSION TITLE: Critical Care Student/Resident Case Report Posters II

SESSION TYPE: Student/Resident Case Report Poster

PRESENTED ON: Tuesday, October 27, 2015 at 01:30 PM - 02:30 PM

INTRODUCTION: One-third of pregnant asthmatics develop a critical asthma syndrome. We present the case of a 38 year old pregnant female with refractory status asthmaticus who ultimately improved with the use of extracorporeal membrane oxygenation (ECMO).

CASE PRESENTATION: A 38 year old African-American female, gravida 1 para 0, at 16 weeks gestation presented to our emergency department (ED) with four days of dry cough and shortness of breath. She has a history of poorly-controlled asthma requiring frequent ED visits, BiPap, and two prior intubations. On presentation, the patient was in severe respiratory distress. She received continuous albuterol-ipratropium, IV magnesium sulfate, IV methylprednisolone, subcutaneous terbutaline and was placed on BiPap with initial ABG demonstrating adequate ventilation and oxygenation. Over the next 36 hours, she developed worsening respiratory distress and hypercapnic respiratory failure requiring intubation. She remained difficult to ventilate despite maximal medical therapy including neuromuscular blockade. A permissive hypercapnia strategy was aborted when the patient developed severe acidosis to pH of 6.8 and hyperkalemia to 9 with associated EKG changes. Given her refractory status asthmaticus, a trial of inhaled anesthesia was initiated using isoflurane which led to improvement in her ventilation and acidosis. However, over the next 24 hours she progressively deteriorated and veno-venous ECMO was initiated. She was maintained on solumedrol, continuous albuterol and ipratropium, IV magnesium sulfate, low-dose epinephrine infusion, continuous aminophylline, and furosemide infusion. The patient's ECMO course was complicated by severe mucosal bleeding and a small intracerebral hemorrhage. A 17-week ultrasound of the fetus revealed ventriculomegaly. After eight days, the patient was successfully weaned off ECMO. She was extubated one week later and eventually discharged to an acute rehabilitation facility.

DISCUSSION: Standard medical therapies including permissive hypercapnia are safe and effective treatments for status asthmaticus in pregnancy. Inhaled isoflurane and ECMO have also been used in adults and children with status asthmaticus refractory to conventional therapy. To the best of our knowledge, neither inhaled isoflurane nor ECMO has been described in a pregnant patient with status asthmaticus.

CONCLUSIONS: Our case demonstrates the successful use of ECMO for near-fatal status asthmaticus in pregnancy. The long term effects of this treatment upon our patient’s fetus remain to be seen.

Reference #1: Chan AL, Juarez MM, Gidwani N, Albertson TE. Management of critical asthma syndrome during pregnancy. Clin Rev Allergy Immunol. 2015 Feb;48(1):45-53

Reference #2: Iwaku F, Otsuka H, Kuraishi H, Suzuki H. The investigation of isoflurane therapy for status asthmaticus patients. Arerugi. 2005 Jan;54(1):18-23

Reference #3: King PT, Rosalion A, McMillan J, Buist M, Holmes PW. Extracorporeal membrane oxygenation in pregnancy. Lancet. 2000 Jul 1;356(9223):45-6

DISCLOSURE: The following authors have nothing to disclose: Maria Theodorou, Emily Gilbert

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543